Sight Sciences (SGHT)
(Delayed Data from NSDQ)
$5.28 USD
+0.14 (2.72%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $5.29 +0.01 (0.19%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Sight Sciences, Inc. (SGHT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$4.70 | $7.00 | $1.80 | -8.56% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for Sight Sciences, Inc. comes to $4.70. The forecasts range from a low of $1.80 to a high of $7.00. The average price target represents a decline of 8.56% from the last closing price of $5.14.
Analyst Price Targets (4 )
Broker Rating
Sight Sciences, Inc. currently has an average brokerage recommendation (ABR) of 2.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 2.67 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, one is Strong Buy, representing 16.67% of all recommendations. A month ago, Strong Buy represented 16.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 5 | 5 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.67 | 2.67 | 2.67 | 2.67 | 2.67 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/10/2024 | Needham & Company | David Saxon | Hold | Hold |
1/9/2024 | Piper Sandler | Matthew O'Brien | Hold | Hold |
9/12/2023 | William Blair | Margaret Kaczor | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.67 |
ABR (Last week) | 2.67 |
# of Recs in ABR | 6 |
Average Target Price | $4.70 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 94 of 252 |
Current Quarter EPS Est: | -0.29 |